[1]
Achten, R.E. et al. 2022. Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis. Acta Dermato-Venereologica. 102, (Mar. 2022), adv00666. DOI:https://doi.org/10.2340/actadv.v102.1128.